IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 47.5

Change

-1.58 (-3.22)%

Market Cap

N/A

Volume

0.26M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-3.12 (-2.32%)

USD 35.08B
FHLC Fidelity® MSCI Health Care In..

-1.56 (-2.45%)

USD 2.50B
FXH First Trust Health Care AlphaD..

-2.83 (-2.73%)

USD 0.90B
XHE SPDR® S&P Health Care Equipme..

-2.55 (-3.06%)

USD 0.16B
IDNA iShares Genomics Immunology an..

-0.39 (-1.91%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

-2.77 (-2.75%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

-0.78 (-2.66%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.83 (-3.00%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

-1.43 (-2.50%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.64 (-3.42%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.23 % 0.00 %

-0.74 (-2.60%)

USD 0.08B
LCR Managed Portfolio Series 0.00 % 0.00 %

-0.28 (-2.60%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.02% 90% A- 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.02% 90% A- 47% F
Trailing 12 Months  
Capital Gain -11.21% 24% F 22% F
Dividend Return 0.57% 56% F 9% A-
Total Return -10.64% 24% F 20% F
Trailing 5 Years  
Capital Gain 22.52% 57% F 45% F
Dividend Return 5.22% 63% D 11% F
Total Return 27.74% 57% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain 2.29% 62% D 46% F
Dividend Return 2.94% 62% D 39% F
Total Return 0.64% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.09% 43% F 52% F
Risk Adjusted Return 15.38% 57% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.